14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of NGM
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

NGM Biopharmaceuticals Inc. stock price down 0% on Wednesday
(Updated on May 01, 2024)

Hold candidate since Apr 05, 2024 PDF

No changes to the price of NGM Biopharmaceuticals Inc. stock on the last trading day (Wednesday, 1st May 2024). During the last trading day the stock fluctuated 0% from a day low at $1.54 to a day high of $1.54. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect NGM Biopharmaceuticals Inc. stock with a 90% probability to be traded between $1.41 and $1.94 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

NGM Signals & Forecast

There are mixed signals in the stock today. The NGM Biopharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.54 and $1.55. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Thursday, April 04, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for NGM Biopharmaceuticals Inc. stock

NGM Biopharmaceuticals Inc. finds support from accumulated volume at $1.53 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $1.45 (-6.00%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 19 days ago.)

Trading Expectations (NGM) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect NGM Biopharmaceuticals Inc. to open at $1.54, and during the day (based on 14 day Average True Range), to move between $1.53 and $1.55, which gives a possible trading interval of +/-$0.0134 (+/-0.87%) up or down from last closing price. If NGM Biopharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 1.74% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.55 (0.65%) than the support at $1.53 (0.65%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

NGM Biopharmaceuticals Inc. will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.300. We will update the financials statements for NGM Biopharmaceuticals Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 5.27% in the first trading day after earnings release.

Is NGM Biopharmaceuticals Inc. stock A Buy?

NGM Biopharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for NGM Biopharmaceuticals Inc. of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
$1.54 ( 0%) $1.54

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for NGM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.54 .
R2 1.54 .
R1 1.54 .
Current price: 1.54
Support S1 1.54 .
S2 1.54 .
S3 1.54 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.63 5.84 %
R2 1.56 1.30 %
R1 1.55 0.649 %
Current price 1.54
Support S1 1.53 -0.649%
S2 1.53 -0.97%
S3 1.52 -1.30%

FAQ

What is the symbol for NGM Biopharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for NGM Biopharmaceuticals Inc. is NGM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell NGM Biopharmaceuticals Inc. Stock?
NGM Biopharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy NGM Biopharmaceuticals Inc. Stock?
NGM Biopharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy NGM Biopharmaceuticals Inc. Stock.

What's the current price of NGM Biopharmaceuticals Inc. Stock?
As of the end of day on the May 01, 2024, the price of an NGM Biopharmaceuticals Inc. (NGM) share was $1.54.

What is the 52-week high and low for NGM Biopharmaceuticals Inc. Stock?
The 52-week high for NGM Biopharmaceuticals Inc. Stock is $4.53 and the 52-week low is $0.600.

What is the market capitalization of NGM Biopharmaceuticals Inc. Stock?
As of the May 01, 2024, the market capitalization of NGM Biopharmaceuticals Inc. is 128.532M.

When is the next earnings date for NGM Biopharmaceuticals Inc.?
The upcoming earnings date for NGM Biopharmaceuticals Inc. is May 02, 2024.
Click to get the best stock tips daily for free!

About NGM Biopharmaceuticals Inc.

NGM Biopharmaceuticals. NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); and MK-3655, an agonistic antibody that ac... NGM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT